Shares of Predictive Oncology Inc. (NASDAQ:POAI – Get Free Report) crossed below its two hundred day moving average during trading on Wednesday. The stock has a two hundred day moving average of $8.03 and traded as low as $7.89. Predictive Oncology shares last traded at $8.30, with a volume of 199,968 shares trading hands.
Predictive Oncology Trading Down 11.6%
The stock’s 50-day moving average price is $10.66 and its 200-day moving average price is $8.06. The stock has a market cap of $26.37 million, a price-to-earnings ratio of -0.58 and a beta of 1.35.
About Predictive Oncology
Predictive Oncology Inc (NASDAQ: POAI) is a biotechnology company focused on applying artificial intelligence and machine learning to oncology drug discovery and precision medicine. The company combines computational tools with biological data to help identify promising therapeutic candidates and predict how individual tumors may respond to specific treatments.
Its technology platform is built around a proprietary collection of tumor samples and associated clinical and drug-response information.
Featured Stories
- Five stocks we like better than Predictive Oncology
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
- Lockheed Martin’s Record $292 Billion Backlog Comes With a Delivery Test
- Palantir’s Next Big Test Isn’t a Partnership—It’s the Numbers
- Kinder Morgan’s $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings Beat
Receive News & Ratings for Predictive Oncology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Predictive Oncology and related companies with MarketBeat.com's FREE daily email newsletter.
